As an expert in the pharmaceutical industry, I can provide you with a comprehensive answer regarding the production of Adderall, a medication commonly prescribed for attention deficit hyperactivity disorder (ADHD). However, before diving into the details, I would like to clarify that my knowledge is based on information available up to the knowledge cutoff date of April 2023, and any changes or updates post that date would not be reflected in my response.
Step 1: English Answer
Adderall is a trademarked medication that contains a combination of amphetamine and dextroamphetamine, which are central nervous system (CNS) stimulants. These stimulants affect chemicals in the brain and nerves that contribute to hyperactivity and impulse control problems. The drug is used to treat both children and adults with ADHD, and it can also be prescribed off-label for other conditions such as narcolepsy.
The original manufacturer of Adderall was a company called Shire, which was based in the United States. Shire Pharmaceuticals was known for developing and producing various medications for rare diseases and specialized conditions. However, it's important to note that there have been significant changes in the pharmaceutical industry since the early 2000s, and the ownership and production of drugs can change hands through mergers, acquisitions, or licensing agreements.
In 2016, Shire relocated its tax residence from the United States to Ireland through a tax inversion maneuver, which is a strategy used by multinational corporations to reduce their tax burden. This move was controversial and faced scrutiny from various stakeholders. Despite this, Shire continued to operate and produce medications, including Adderall.
However, in 2019, Shire was acquired by another pharmaceutical giant, Takeda Pharmaceutical Company, based in Japan. Takeda is a global company with a diverse portfolio of medicines, and with the acquisition, Shire's products, including Adderall, became part of Takeda's product lineup. It's worth mentioning that the production and distribution of a drug can involve multiple parties, including the original developer, manufacturers, and distributors, each playing a role in the process.
Regarding the claim you mentioned about Shire Pharmaceuticals being fined for exaggerating the benefits of its drugs, including Adderall XR and Vyvanse, this is a serious allegation. Pharmaceutical companies are regulated by various authorities, including the U.S. Food and Drug Administration (FDA), and they are expected to market their products truthfully and without misleading claims. If a company is found to have violated these regulations, they can face significant penalties, as was the case with Shire in 2014.
It's also important to highlight that while Adderall is an effective medication for many patients with ADHD, it is a controlled substance and has the potential for abuse. Therefore, it is tightly regulated, and its prescription and use are subject to strict guidelines to ensure patient safety and to prevent misuse.
In summary, Adderall is a medication that has been produced by different companies over the years. As of my last update, the production and distribution of Adderall are under the umbrella of Takeda Pharmaceutical Company, following their acquisition of Shire. It's always a good idea to check the most current information from reliable sources or directly from the company for the latest details on drug production and distribution.
**read more >>

Irish drugmaker Shire Pharmaceuticals has been ordered to pay a $56.5 million fine to settle claims that it exaggerated the benefits of several of its drugs, including Adderall XR and Vyvanse, both used to treat attention deficit hyperactivity disorder (ADHD).Sep 26, 2014read more >>